Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ABBOTT LABORATORIES ABT

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.


NYSE:ABT - Post by User

Post by zayaroy18on Jun 13, 2022 6:43am
152 Views
Post# 34750968

Global Fractional Flow Reserve Market to Grow at 12.1% IMARC

Global Fractional Flow Reserve Market to Grow at 12.1% IMARC

According to the latest report by IMARC Group, titled Fractional Flow Reserve Market Size: Global Industry Trends, Share,  Growth, Opportunity and Forecast 2022-2027,”The global fractional flow reserve market is expected to exhibit a CAGR of 12.1% during 2022-2027.

Fractional flow reserve (FFR) is a techniquethat assists in the coronary catheterization for measuring pressure differences across coronary artery stenosis. It evaluatesthe ratio between the achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery. It comprises specialized guidewires that efficiently penetrate through arteries and identify blockages to determine the surgical procedures required.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Global Fractional Flow Reserve Market Trends:

At present, healthcare professionals are relying on FFR as it is cost-effective and aids in saving lives while avoiding unnecessary surgical procedures.This represents one of the major factors creating a positive outlook for the market. Additionally, the increasing geriatric population, which is more vulnerable to cardiovascular diseases (CVDs), is driving the market. Furthermore, unhealthy eating patterns, physical inactivity, hypertension, and high BMI, cholesterol and glycemic levels are resulting in the growing prevalence of heart diseases.This, coupled with rising research and development (R&D) activities to improve overall outcomes while using FFR, is impelling the market growth.

Request Free Sample Report: https://www.imarcgroup.com/fractional-flow-reserve-market/requestsample

Global Fractional Flow Reserve Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, ACIST Medical Systems Inc. (Bracco S.p.A.), Boston Scientific Corporation, CathWorks Ltd., Heartflow Inc., Koninklijke Philips N.V., Medis Medical Imaging Systems B.V., Opsens Inc. , Pie Medical Imaging B.V. (Esaote Group), Siemens Healthineers AG and Terumo Medical Corporation.

The report has segmented the market on the basis on region, product, application and end user.

Breakup by Product:

  • FFR Guidewires
  • FFR Monitoring Systems

Breakup by Application:

  • Multi-Vessel Coronary Artery Disease
  • Single-Vessel Coronary Artery Disease

Breakup by End User:

  • Hospitals and Ambulatory Surgery Centers
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/fractional-flow-reserve-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 

 

<< Previous
Bullboard Posts
Next >>